• $4.5B
    Market Cap
  • 211.55%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
RTW INVESTMENTS, LP
8.24%
13.9M
+600,000 (+4.32%)
Jun 30, 2026
BLACKROCK, INC.
7.38%
12.4M
+3.7M (+29.67%)
Jun 30, 2026
FMR LLC
7.31%
12.3M
+2.4M (+19.68%)
Jun 30, 2026
FARALLON CAPITAL MANAGEMENT LLC
7.28%
12.3M
+3.2M (+25.90%)
Jun 30, 2026
BOXER CAPITAL MANAGEMENT, LLC
6.45%
10.9M
0 (0.00%)
Jun 30, 2026
ECOR1 CAPITAL, LLC
6.30%
10.6M
0 (0.00%)
Sep 30, 2025
GOLDMAN SACHS GROUP INC
5.92%
10.0M
+4.9M (+49.14%)
Jun 30, 2026

Current Ownership Distribution

  • Institutions2.0B (87.08%)
  • Mutual Funds247.7M (10.55%)
  • Insiders55.5M (2.37%)
  • Other0 (0.00%)

Insider Transactions

  • 2.37% (55.5M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 3
    Number of InsiderSelling (last 12 months)
  • $160.6M
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Crystal Adam
President, R&D
Exempt
Oct 01, 2026
$0.00
27,000
$0.00
233,040
Crystal Adam
President, R&D
Exempt
Oct 01, 2026
$140,400.00
27,000
$5.20
142,743
Crystal Adam
President, R&D
Sell
Oct 01, 2026
$645,604.08
26,400
$24.45
116,343
Crystal Adam
President, R&D
Sell
Oct 01, 2026
$15,192.00
600
$25.32
115,743
Newcomb Jessica
Principal Accounting Officer
Sell
Sep 22, 2026
$15,962.03
700
$22.80
66,621
Newcomb Jessica
Principal Accounting Officer
Sell
Sep 22, 2026
$122,238.33
5,100
$23.97
61,521
Newcomb Jessica
Principal Accounting Officer
Sell
Sep 22, 2026
$60,412.32
2,400
$25.17
59,121
Crystal Adam
President, R&D
Exempt
Aug 03, 2026
$0.00
27,000
$0.00
287,040
Crystal Adam
President, R&D
Exempt
Aug 03, 2026
$140,400.00
27,000
$5.20
142,743
Crystal Adam
President, R&D
Sell
Aug 03, 2026
$141,100.30
5,267
$26.79
137,476
Crystal Adam
President, R&D
Sell
Aug 03, 2026
$594,417.11
21,733
$27.35
115,743
Crystal Adam
President, R&D
Exempt
Jul 01, 2026
$0.00
27,000
$0.00
314,040
Crystal Adam
President, R&D
Exempt
Jul 01, 2026
$140,400.00
27,000
$5.20
142,743
Crystal Adam
President, R&D
Sell
Jul 01, 2026
$575,961.97
19,629
$29.34
123,114
Crystal Adam
President, R&D
Sell
Jul 01, 2026
$222,946.21
7,371
$30.25
115,743
Crystal Adam
President, R&D
Exempt
Apr 01, 2026
$0.00
27,000
$0.00
433,500
Crystal Adam
President, R&D
Exempt
Apr 01, 2026
$140,400.00
27,000
$5.20
139,622
Crystal Adam
President, R&D
Sell
Apr 01, 2026
$572,478.30
27,000
$21.20
112,622
Crystal Adam
President, R&D
Sell
Mar 05, 2026
$303,765.00
20,251
$15.00
112,622
Crystal Adam
President, R&D
Sell
Feb 03, 2026
$223,707.98
18,251
$12.26
187,419
Crystal Adam
President, R&D
Sell
Feb 03, 2026
$2,592.32
201
$12.90
187,218
Crystal Adam
President, R&D
Award
Feb 02, 2026
$0.00
284,760
$0.00
284,760
Crystal Adam
President, R&D
Award
Feb 02, 2026
$0.00
47,460
$0.00
205,670
Peters Malte
President & CEO
Award
Jan 08, 2026
$0.00
1.6M
$0.00
1.6M
Peters Malte
President & CEO
Award
Jan 08, 2026
$0.00
350,000
$0.00
367,500
Lee Sung
Award
Jan 02, 2026
$0.00
60,000
$0.00
60,000
Lee Sung
Award
Jan 02, 2026
$0.00
10,000
$0.00
10,000
Peters Malte
Award
Nov 03, 2025
$0.00
150,000
$0.00
150,000
Third Rock Ventures IV, L.P.
Sell
Oct 23, 2025
$4.8M
477,401
$10.15
13.4M
Third Rock Ventures IV, L.P.
Sell
Sep 25, 2025
$4.0M
500,000
$8.02
13.9M